Navigation Links
Bionovo Reports Second Quarter 2008 Financial Results
Date:8/5/2008

097

Merger cost - - 1,964,065

Total operating expenses 8,570,366 6,327,616 33,778,403

Loss from operations (8,570,366) (6,320,116) (33,118,913)

Change in fair value of

warrant liability - - 831,288

Interest income 495,747 347,687 1,564,163

Interest expense (61,912) (26,527) (298,929)

Other income (expense) (15,616) - 129,281

(8,152,147) (5,998,956) (30,893,110)

Loss before income tax

Income tax provision (3,256) (2,400) (12,258)

$(8,155,403) $(6,001,356) $(30,905,368)

Net loss

Basic and diluted net loss

per common share $ (0.11) $ (0.09) $ (0.78)

Shares used in computing

basic and diluted

net loss per common share 76,343,649 63,388,724 39,407,904

Bionovo, Inc.

(A Development Stage Company)

Condensed Balance Sheets

June 30, December 31,

2008 2007

(Unaudited) (Note 1)

ASSETS

Current assets:

Cash and cash equivalents $11,918,365 $28,472,485

Short-term investments 12,698,636 4,823,938

Receivables 136,904 285,899

Prepaid expenses and other current assets 1,027,786 405,381

Total current assets 25,781,691 33,987,70
'/>"/>

SOURCE Bionovo, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Bionovo to Present at A.G. Edwards 2nd Annual Emerging Growth Conference 2007
2. Bionovo Announces Proposed Public Offering of Common Stock
3. Bionovo to Present at the Biotechnology Industry Organization (BIO) Investor Forum
4. Bionovo Announces the Pricing of Public Offering of Shares of Common Stock
5. Bionovo Announces Third Quarter 2007 Financial Results
6. Bionovo to Present at Bank of Montreals 2007 Focus on Healthcare Conference
7. George Butler Joins Bionovos Board of Directors
8. Louis Drapeau Joins Bionovos Board of Directors
9. Bionovo Identifies and Describes ER-beta Selective Compounds for the Treatment of Vaginal Dryness
10. Bionovo to Present Recent Findings of BN107 and BN108, Its Anticancer Agents, at the American Association of Cancer Research
11. Bionovo Reports First Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 24, 2013 Die Übersetzungen wurden ... Bei der englischen Version handelt es ... % der Teilnehmer einer groß angelegten Asthmaumfrage halten ihren ... GINA [*] -Definition [1] als kontrolliert gelten können ... generell einer von vier Denkweisen zugeordnet werden können, die ...
(Date:5/23/2013)... stopped breathing, his collapsed bronchus blocking the crucial flow ... watched helplessly, just praying that somehow the dire predictions ... had a good chance of not leaving the hospital ... Kaiba. "At that point, we were desperate. Anything that ... it." , They found hope at the University of ...
(Date:5/23/2013)... Colo. , May 23, 2013 Venaxis, ... diagnostic company focused on obtaining FDA clearance and commercializing ... today announced the pricing of an underwritten public offering ... warrants to purchase 3,500,000 shares of its common stock ... a combined public offering price of $1.25 per share ...
(Date:5/23/2013)... , May 23, 2013  BioScrip, Inc. (NASDAQ: ... will present at the Jefferies 2013 Global Healthcare Conference ... Hyatt New York. Richard Smith ... Hai Tran , Chief Financial Officer, will ... Eastern Daylight Time.   About BioScrip ...
Breaking Biology Technology:Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 2Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 3Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 4Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 5Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 6Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 7Baby's life saved with groundbreaking 3-D printed device that restored his breathing 2Baby's life saved with groundbreaking 3-D printed device that restored his breathing 3Venaxis Announces Pricing of Offering of Common Stock and Warrants 2Venaxis Announces Pricing of Offering of Common Stock and Warrants 3
... who have been dreaming of mobile devices that run ... wish has been granted. University of Illinois engineers ... is faster and uses 100 times less energy than ... devices much longer battery life between charges. Led ...
... Inc. (Nasdaq: MYL ) today announced that ... from the U.S. Food and Drug Administration (FDA) under ... its New Drug Application (NDA) for Zidovudine Tablets, 100 ... drug Retrovir® Tablets, by ViiV Healthcare. This pediatric antiretroviral ...
... (Nasdaq CM: INSMD), a biopharmaceutical company, today reported results ... 2010. Key Recent Highlights: ... 2011 with the FDA to begin a phase 3 ... non-TB Mycobacteria (NTM) lung infections. Successfully concluded 72 ...
Cached Biology Technology:New technology would dramatically extend battery life for mobile devices 2New technology would dramatically extend battery life for mobile devices 3Mylan's Matrix Receives FDA Approval Under PEPFAR for Zidovudine Tablets, 100 mg 2Insmed Announces Fourth Quarter and Full-Year 2010 Financial Results 2Insmed Announces Fourth Quarter and Full-Year 2010 Financial Results 3Insmed Announces Fourth Quarter and Full-Year 2010 Financial Results 4Insmed Announces Fourth Quarter and Full-Year 2010 Financial Results 5Insmed Announces Fourth Quarter and Full-Year 2010 Financial Results 6Insmed Announces Fourth Quarter and Full-Year 2010 Financial Results 7Insmed Announces Fourth Quarter and Full-Year 2010 Financial Results 8
(Date:5/23/2013)... Frontiers in Plant Science , ... gene content and promoter evolution among grasses , ... of stretches of DNA that undergo little change in ... not code for any proteins. Some of these evolutionarily ... to regulate the expression of other genes or the ...
(Date:5/23/2013)... fruit, can be made both better-tasting and longer-lasting thanks ... "Working with GM tomatoes that are different to normal ... allows us to pinpoint exactly how to breed in ... Innes Centre. , The research could also lead to ... characteristics because even higher levels of the compounds can ...
(Date:5/23/2013)... Laboratory honored more than 165 staff for their ... PNNL,s annual Intellectual Property Commercialization Recognition & Rewards ... national laboratory named materials scientist Jun Liu Inventor ... materials that can store large amounts of energy, ... the time it takes to charge cell phones, ...
Breaking Biology News(10 mins):Frontiers news briefs: May 23 2Frontiers news briefs: May 23 3The world's favorite fruit only better-tasting and longer-lasting 2PNNL staff recognized for scientific accomplishments, moving technologies into the marketplace 2
... Institute, an NCI-designated cancer center at NYU Langone Medical ... Diffuse Large B-Cell Lymphoma (DLBCL), the most aggressive and ... published in the November 23 issue of Nature ... development of lymphomagenesis. "We have discovered that ...
... 28, 2011) -- Scientists at Weill Cornell Medical College used ... specially engineered for the study of cleft lip and cleft ... or treat the conditions in humans. Cleft lip and ... treatment requiring multiple cycles of surgery, speech therapy and orthodontics. ...
... published by Pensoft reported a substantial growth in 2011, ... jubilee 150th issue, By the end of November 2011, the ... compare with 4,962 pages and 180 articles in 2010). Since ... than 19,000 pages and 780 articles of valuable information on ...
Cached Biology News:New potential therapeutic target identified for Diffuse Large B-Cell Lymphoma 2Cleft lip corrected genetically in mouse model 2Cleft lip corrected genetically in mouse model 3Growth through innovations and open access: The journal ZooKeys on point for digital taxonomy 2
... Pichia Protocols is the first all-inclusive ... the Pichia pastoris Expression System. Methods developed ... provided as detailed, step-by-step protocols. This book ... expression vector, through strain construction and analysis, ...
Rad 51C Immunogen: His-tagged human Rad 51C, over-expressed in E. coli Storage: 4 C...
...
...
Biology Products: